Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...

The Cleveland bank is working with Personetics to provide advice and help to digital banking customers that takes into ...

Blarcamesine appeared to slow the decline of cognition and functional capacity for people with Alzheimer’s disease in a ...

Blarcasemine met its primary endpoints, improving cognition and function over a four year period in early-stage Alzheimer’s ...

Anavex reported that early use of blarcamesine in Alzheimer's trials led to sustained cognitive and functional improvements over 4 years.

Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk ( ...

A structured approach to exercise, diet, brain training, social engagement and clinical testing yielded greater cognitive ...